Psyence Group (XCNQ:PSYG) Asset Impairment Charge : C$-0.06 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Psyence Group Asset Impairment Charge?

Psyence Group's Asset Impairment Charge for the three months ended in Sep. 2024 was C$0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 was C$-0.06 Mil.

Psyence Group Asset Impairment Charge Historical Data

The historical data trend for Psyence Group's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Group Asset Impairment Charge Chart

Psyence Group Annual Data

Trend

Dec19

Dec20

Mar22

Mar23

Mar24

Asset Impairment Charge

0.05

-0.01

Psyence Group Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Asset Impairment Charge	Get a 7-Day Free Trial											-	-0.01	-0.05	-	-

Psyence Group Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.06 Mil.

Psyence Group Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Psyence Group's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Psyence Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Psyence Group Inc (XCNQ:PSYG) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

PSYGF:USA

Address

121 Richmond Street West, Penthouse Suite, 1300, Toronto, ON, CAN, M5H 2K1

Website

https://www.psyence.com

Psyence Group Inc is a life science biotechnology company focused on the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and in support of mental wellness.

Executives

Jody Aufrichtig	Director, Senior Officer
Warwick Corden-lloyd	Senior Officer
Neil Maresky	Senior Officer

Psyence Group Headlines

No Headlines